Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

ICP-MS Analysis Of Lanthanide-doped Nanoparticles As A Non-radiative, Multiplex Approach To Quantify Biodistribution And Blood Clearance.

S. Crayton, Drew R. Elias, A. Al Zaki, Zhiliang Cheng, A. Tsourkas
Published 2012 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Recent advances in material science and chemistry have led to the development of nanoparticles with diverse physicochemical properties, e.g. size, charge, shape, and surface chemistry. Evaluating which physicochemical properties are best for imaging and therapeutic studies is challenging not only because of the multitude of samples to evaluate, but also because of the large experimental variability associated with in vivo studies (e.g. differences in tumor size, injected dose, subject weight, etc.). To address this issue, we have developed a lanthanide-doped nanoparticle system and analytical method that allows for the quantitative comparison of multiple nanoparticle compositions simultaneously. Specifically, superparamagnetic iron oxide (SPIO) with a range of different sizes and charges were synthesized, each with a unique lanthanide dopant. Following the simultaneous injection of the various SPIO compositions into tumor-bearing mice, inductively coupled plasma mass spectroscopy (ICP-MS) was used to quantitatively and orthogonally assess the concentration of each SPIO composition in serial blood samples and the resected tumor and organs. The method proved generalizable to other nanoparticle platforms, including dendrimers, liposomes, and polymersomes. This approach provides a simple, cost-effective, and non-radiative method to quantitatively compare tumor localization, biodistribution, and blood clearance of more than 10 nanoparticle compositions simultaneously, removing subject-to-subject variability.
This paper references
10.1517/17425247.2011.554818
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
P. Karmali (2011)
10.1148/RADIOLOGY.197.2.7480707
MR imaging of phagocytosis in experimental gliomas.
C. Zimmer (1995)
Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme.
V. Muzykantov (1991)
10.1016/B978-0-08-055294-1.00102-1
3.318 – Molecular Imaging
S. Crayton (2011)
10.1021/BC025633C
Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
Hisataka Kobayashi (2003)
10.3109/09687688.2010.522117
Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)
R. B. Huang (2010)
10.1148/RADIOL.2211001784
Human transferrin receptor gene as a marker gene for MR imaging.
A. Moore (2001)
10.1042/BST0350061
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
D. Tomalia (2007)
10.1016/j.biomaterials.2007.12.037
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
W. D. de Jong (2008)
Biological approaches to the controlled delivery of drugs: a critical review.
M. Poznansky (1984)
10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K
Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent
W. S. Enochs (1999)
10.1002/smll.201001389
Engineering Nanocarriers for siRNA Delivery.
S. J. Tan (2011)
10.1016/j.biomaterials.2008.05.015
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
10.1097/MOP.0b013e32834456a5
Recent progress in the therapeutic applications of nanotechnology
Melani A Solomon (2011)
10.1186/1741-7015-8-83
Advances in the field of nanooncology
K. Jain (2010)
10.1148/RADIOLOGY.214.2.R00FE19568
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
A. Moore (2000)
10.4155/fmc.10.3
Nanotechnology and MRI contrast enhancement.
Michael L Matson (2010)
10.1016/S0378-5173(02)00218-1
Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting.
A. Cahouet (2002)
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
S. Moghimi (1994)
10.1039/DF9511100055
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
Engineering nanocarriers for siRNA delivery. Small 2011;7:841e56
SJ Tan (2011)
10.3109/02652049609026013
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
10.2217/nnm.11.19
Nanoparticle PEGylation for imaging and therapy.
J. Jokerst (2011)
10.1189/jlb.0205074
Nanotechnology for the biologist
S. Mcneil (2005)
10.1021/nl900031y
Mediating tumor targeting efficiency of nanoparticles through design.
Steven D. Perrault (2009)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1366/11-06255
Review of the State-of-the-Art of Laser Ablation Inductively Coupled Plasma Mass Spectrometry
J. Koch (2011)
10.1006/exnr.1996.6350
Tumor Cell Endocytosis Imaging Facilitates Delineation of the Glioma–Brain Interface
C. Zimmer (1997)
10.1002/CHIN.201119272
Nanoparticles in Biological Systems
W. Stark (2011)
10.1007/s10439-005-9002-7
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
D. Thorek (2005)
10.1002/mrm.1314
Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores
N. Sato (2001)
10.1007/s00216-011-5144-7
Using laser ablation/inductively coupled plasma mass spectrometry to bioimage multiple elements in mouse tumors after hyperthermia
Yi-Kong Hsieh (2011)



This paper is referenced by
10.1016/j.nano.2015.12.382
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties.
L. E. Roode (2016)
10.1002/9783527803835.CH9
Nanocellulose and Nanogels as Modern Drug Delivery Systems
M. Moscovici (2017)
10.1016/J.JLUMIN.2018.06.042
Maximizing dopant photoluminescence in co-doped semiconductor nanoparticles for multiplex assays by tuning inter dopant electronic interactions: Synthetic co-doping or physical mixing of singly doped moieties?
A. Chakraborty (2018)
10.1021/acsnano.7b05377
Nanoparticle Biokinetics in Mice and Nonhuman Primates.
P. Chiarelli (2017)
10.1038/ncomms10432
In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics
Xiangzhao Ai (2016)
10.1039/C3JA30373J
Metal/dye-doped core-shell silica nanoparticles for potential use in bioassay
J. A. Ko (2013)
10.3233/THC-161285
Europium doping of superparamagnetic iron oxide nanoparticles enables their detection by fluorescence microscopy and for quantitative analytics.
Yuske Kobayashi (2017)
10.1016/B978-0-12-801329-8.00013-1
Metabolomic profiling of neoplastic lesions in mice.
Xiaojie Lu (2014)
10.1021/ac4036668
Multicore magnetic nanoparticles (MMNPs) doped with Cs and FITC for the determination of biomarker in serum using ICP-MS.
Jungaa Ko (2014)
10.1134/S1061934815090166
Role of mass spectrometry in the development and medicinal implementation of metal-based nanoparticles
A. Timerbaev (2015)
10.1016/j.msec.2017.02.023
Complementary approaches for the evaluation of biocompatibility of 90Y-labeled superparamagnetic citric acid (Fe,Er)3O4 coated nanoparticles.
B. Antic (2017)
10.1021/nn304160p
Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.
Ching-Hui Huang (2012)
10.1038/ncomms10432
In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics
Xiangzhao Ai (2016)
10.1016/j.jconrel.2015.10.038
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.
V. Podust (2016)
10.1002/MACP.201700592
Preparation of PEGylated Iodine‐Loaded Nanoparticles via Polymer‐Directed Self‐Assembly
C. Tang (2018)
10.1080/17435390.2020.1829144
Comparative acute intravenous toxicity study of triple polymer-layered magnetic nanoparticles with bare magnetic nanoparticles in Swiss albino mice
Anas Ahmad (2020)
10.1039/C6RA06719K
Bio-distribution and in vivo/in vitro toxicity profile of PEGylated polymer capsules encapsulating LaVO4:Tb3+ nanoparticles for bioimaging applications
C. R. Dhanya (2016)
10.2217/nnm-2017-0043
Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.
G. Pietersz (2017)
10.1016/j.nano.2012.05.015
Effect of ligand density, receptor density, and nanoparticle size on cell targeting.
Drew R. Elias (2013)
10.1088/1361-6528/aafa3a
Magnetometry based method for investigation of nanoparticle clearance from circulation in a liver perfusion model.
I. V. Zelepukin (2019)
10.1016/j.jconrel.2020.07.014
Fast processes of nanoparticle blood clearance: Comprehensive study.
I. V. Zelepukin (2020)
10.1038/srep39119
Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles
Yuan-Chin Hsieh (2016)
10.1007/978-94-024-0951-2_14
Safety Assessment of Nanoprobes
Y. Liu (2017)
10.1021/ac301852y
Simultaneous quantification of tumor uptake for targeted and nontargeted liposomes and their encapsulated contents by ICPMS.
Zhiliang Cheng (2012)
10.2147/IJN.S32828
Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure
Changmoon Lee (2012)
10.3390/s131013732
Sensing Lanthanide Metal Content in Biological Tissues with Magnetic Resonance Spectroscopy
Dina V. Hingorani (2013)
10.1021/acs.analchem.5b02466
High-Speed, Integrated Ablation Cell and Dual Concentric Injector Plasma Torch for Laser Ablation-Inductively Coupled Plasma Mass Spectrometry.
David N. Douglas (2015)
10.1039/C5JA00132C
Considerations of inductively coupled plasma mass spectrometry techniques for characterizing the dissolution of metal-based nanomaterials in biological tissues
Cheng-Kuan Su (2015)
10.1021/acs.molpharmaceut.6b00753
Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS.
R. Ferrari (2017)
10.1039/C4TB01141D
Nanogel Carrier Design for Targeted Drug Delivery.
D. Eckmann (2014)
10.1039/c8nr02278j
Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties.
S. Mourdikoudis (2018)
10.1038/srep05840
Quantitative Comparison of Tumor Delivery for Multiple Targeted Nanoparticles Simultaneously by Multiplex ICP-MS
A. Elias (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar